MTIP
WST icon

Magee Thomson Investment Partners’s West Pharmaceutical WST Stock Holding History

Magee Thomson Investment Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$9.26M Sell
113,500
-26,500
-19% -$2.22M 3.58% 12
2016
Q4 		$11.9M Sell
140,000
-4,900
-3% -$385K 4.12% 10
2016
Q3 		$10.8M Buy
+144,900
New +$11.5M 3.57% 16

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Magee Thomson Investment Partners's WST Position: Q1 2017 in Review

Magee Thomson Investment Partners reduced its West Pharmaceutical (WST) stake by 19% in Q1 2017, selling an estimated $2.22M and leaving 113,500 shares worth $9.26M. The position accounts for 3.58% of the portfolio, ranked #12.

Magee Thomson Investment Partners first reported a position in WST in Q3 2016 and has held it in 3 quarters since. The position peaked at $11.9M in Q4 2016. 294 funds tracked by Wall St. Rank hold WST as of Q1 2017.

  • Magee Thomson Investment Partners held 113,500 shares of West Pharmaceutical worth $9.26M as of Q1 2017.
  • Magee Thomson Investment Partners sold 26,500 West Pharmaceutical shares in Q1 2017, an estimated $2.22M.
  • West Pharmaceutical made up 3.58% of Magee Thomson Investment Partners's portfolio in Q1 2017, its #12 holding.
  • Magee Thomson Investment Partners first reported a position in West Pharmaceutical in Q3 2016 and has held it in 3 quarters since.
  • Magee Thomson Investment Partners's West Pharmaceutical position peaked at $11.9M in Q4 2016.
  • 294 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2017.

Based on Magee Thomson Investment Partners's 13F filing for Q1 2017, filed 21 Apr 2017.